The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
PredictrPK IFX is now available for both the induction and maintenance phases of infliximab (IFX) therapy for inflammatory bowel disease (IBD) patients PredictrPK IFX addresses the unmet need of ...
The Supreme Court unanimously tossed out medical patent claims for Prometheus Laboratories on Tuesday for a test that could help doctors set drug doses for autoimmune diseases like Crohn's disease, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results